Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Oct 01, 2022. (Total: 49787 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 1401 Records)

Next

Query Trace: all[original query]>>Hereditary Cancer[Category]
Genetics of Pancreatic Neuroendocrine Tumors.
Mohindroo Chirayu et al. Hematology/oncology clinics of North America 2022
Characterization of lung cancers in patients with BRCA germline variants: A multicenter series.
Sanchis-Borja Mateo et al. Lung cancer (Amsterdam, Netherlands) 2022 17367-70
Comparison of psychological distress for breast, ovarian and colorectal cancer predisposition in a Spanish sample at high risk of hereditary cancer.
Costa-Requena Gema et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2022 31(5) 482-486
Multiple primary cancers in men with sporadic or familial prostate cancer: Its clinical implications.
Kim Myong et al. Urologic oncology 2022
Hereditary Breast and Ovarian Cancer Week in Michigan: September 25 – October 1, 2022
Gretchen Whitmer, governor of Michigan proclaims September 25 - October 1, 2022, as Hereditary Breast and Ovarian Cancer Week in Michigan.
Familial Pancreatic Cancer.
Saba Helena et al. Gastroenterology clinics of North America 2022 51(3) 561-575
Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.
Llorin Hannah et al. Cancer genetics 2022 268-26922-27
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Whitworth Pat W et al. JAMA network open 2022 5(9) e2232787
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.
Lakeman Inge M M et al. Journal of medical genetics 2022
Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer.
McCarthy Anne Marie et al. Breast cancer research and treatment 2022
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics.
Bednar Erica M et al. Journal of genetic counseling 2022
Current Screening Strategies for Pancreatic Cancer.
Vanek Petr et al. Biomedicines 2022 10(9)
Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.
Loveday C et al. Annals of oncology : official journal of the European Society for Medical Oncology 2022
Ultrasonography screening in children and adolescents who have one parent with familial non-medullary thyroid carcinoma.
Rosario Pedro W et al. Journal of paediatrics and child health 2022
High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer
N Flaum et al, Genetics in Medicine, September 28, 2022
What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?
Leite Ana Carolina Rathsam et al. Frontiers in oncology 2022 12963910
Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women.
Zhang Jingwen et al. American journal of preventive medicine 2022
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.
Puccini Alberto et al. Cancers 2022 14(18)
Communicating Personal Melanoma Polygenic Risk Information: Participants’ Experiences of Genetic Counseling in a Community-Based Study
AK Smit et al, J Per Med, September 26, 2022
Mutation of breast cancer susceptibility genes increases cerebral microbleeds: A pilot study.
Pope Brandon et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022 31(11) 106729
Role of genetic testing in hepatic, pancreatic, and biliary cancers.
Hewitt D Brock et al. Surgical oncology 2022 44101844
Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
Wu Peihong et al. BioMed research international 2022 20222988159
Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
Ansar Safa et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Truong Hong et al. European urology 2022
Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.
Wang Fanke et al. Medicine 2022 101(35) e30141
Familial component of early-onset colorectal cancer: opportunity for prevention.
Daca-Alvarez Maria et al. The British journal of surgery 2022
Systems approach to enhance Lynch syndrome diagnosis through tumour testing.
Singh Vinit et al. Journal of medical genetics 2022
Eligibility, uptake and response to germline genetic testing in women with DCIS.
Turza Lauren et al. Frontiers in oncology 2022 12918757
An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes.
Schwartz Alison et al. Frontiers in oncology 2022 12942741
Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
Murphy Brittany L et al. Annals of surgical oncology 2022
TOP